Roger Chammas

He graduated in Medicine (1988) and obtained a Ph.D. in Biological Sciences (Biochemistry, 1993) from the Universidade de São Paulo (USP), in collaboration with the Ludwig Institute for Cancer Research, São Paulo. He specialized in Glycobiology at the University of California, San Diego (1994–1997). He served as a visiting researcher at the Friedrich Miescher Institute, Basel, Switzerland (1991); Harvard School of Public Health, Boston, United States (1993); Universidade Federal de São Paulo (UNIFESP-EPM, 1998–1999); Moffitt Cancer Research Center, Tampa, United States (2011–2012); and the University of California, Davis (2019). He has been a faculty member at the Faculdade de Medicina da USP since 2001 and a Full Professor of Oncology (Basic Oncology) since 2009. Additionally, he has been an adjunct professor in the Department of Chemistry at the University of North Carolina, Charlotte, since 2016. He directs the Translational Oncology Research Center at the Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da USP, and coordinates the Comprehensive Center for Precision Oncology (C2PO) at USP. He is a member of the Union for International Cancer Control (since 1991), the American Association for Cancer Research (since 1995), the Brazilian Society for Cell Biology (since 2004), and the Brazilian Academy of Sciences (since 2013). He serves on the editorial boards of Frontiers in Oncology, Cancer Biomarkers, and JNCI: Journal of the National Cancer Institute. His research interests focus on Cancer Biology (Biochemistry and Cell Biology of Cancer), particularly tumor progression, carbohydrate-dependent progression markers, and the characterization of tumor microenvironments and their role in tumor resistance to various treatments. His work serves as a platform for innovation in cancer diagnosis and therapy. (Translated from Currículo Lattes)

Currículo Lattes

Biblioteca Virtual FAPESP

ORCID

Scopus

Google Scholar

Web of Science

ResearchGate